The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations
Year: 2022
Type: review
Abstract: Schizophrenia is a severely debilitating neurodevelopmental disorder that requires continuous multidisciplinary treatment. Early onset schizophrenia (EOS, onset before 18) is associated with poorer outcomes than the adult-onset type. The transition from adolescent to adult mental healthcare services (AMHS) poses various challenges for maintaining continuity of care. The heterogeneous availability of specialized mental health services and resources for people with schizophrenia across Europe and the inadequacy of training programs in creating a shared culture and knowledge base between child and adult mental health professionals are major challenges at the policy level. More flexible and individualized transition timing is also needed. While changes in the relationship between patients, caregivers and mental health professionals at a time when young people should acquire full responsibility for their own care are challenges common to all mental health disorders, these are particularly relevant to the care of schizophrenia because of the severe associated disability. This Expert Opinion Paper examines the main aspects of transitioning of care in schizophrenia with the aim of identifying the challenges and the potential approaches that could enhance continuity of care.
Source: European Neuropsychopharmacology
Institutions: Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Hofstra University, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Stiftung Charité, Charité – Universitätsmedizin Berlin, University of Lisbon, Innsbruck Medical University, University of Turin
Language: English
Subfield: Speech and Hearing
Field: Health Professions
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
Funders: Fundación Alicia Koplowitz, European Commission, Ministerio de Ciencia e Innovación, Angelini Pharma, Centro de Investigación Biomédica en Red de Salud Mental, Innovative Medicines Initiative, Horizon 2020 Framework Programme, Instituto de Salud Carlos III, European Regional Development Fund
Awards: G1033681661, G1075404386, Evaluación de la eficacia de una intervención preventiva sobre la prevalencia de bullying y el estado de salud en niños y adolescentes: Ensayo clínico aleatorizado por clusters, G1743590445, G1886919625, G2017605187, G2166927188, G2628364946, G3421866168, G3449207296, G3764841371, G3858309480, G3920792168, G4637685055, G4937468798, G5517320352, G5659272630, G5983053349, G6081615879, G6117018885, G6446975009, Autism Innovative Medicine Studies – 2 – Trials, G7336256237, Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916, G8351277590, G8384605376, G8824911526, G8950770007
OpenAlex ID: W4229370897